ELIC · Elicera Therapeutics AB
Market Cap
182.52M SEK
Shares
66.74M
Price & Indicators
20d MA
50d MA
200d MA
Earnings
Investor day
Close2.7750 SEK
Open2.8550 SEK
Day2.7100–2.8650 SEK
52W close2.2950–7.4000 SEK
Avg vol 30d279K
Last earningsFeb 16, 2027
DataJun 2021–Oct 2026
Technicals
trend & momentum for long-term holders illustrative — not investment advicePrice context
position in its 52-week range
Range low 2.2950 SEK
Now 2.7750 SEK · 9%
Range high 7.4000 SEK
vs 200-day avg -29%
vs 50-day avg +3%
Illustrative technical + ownership context — a signal mix, not investment advice.
Performance
| 5D | 20D | 120D | MTD | YTD | |
|---|---|---|---|---|---|
| FNSE:ELIC | +4.1% | -1.9% | -49.0% | +0.2% | -46.8% |
Exchange listing
- Market
- FNSE
- Ticker
- ELIC
- ISIN
- SE0015382080
- Security
- —
- Trading currency
- SEK
Company
- Website
- https://www.elicera.com/
- Investor relations
- https://www.elicera.com/investors
Other listings of this company
No other verified listings are available.
Recent dividends
No verified dividend payments are available for this listing yet.
Upcoming investor events
| Date | Event | Type |
|---|---|---|
| 2026-11-27 00:00 UTC | Q3-report: 2026-11-27 | Results publication |
| 2027-02-16 00:00 UTC | Year-End Report 2026: 2027-02-16 | Results publication |
Earnings calls
-
Earnings call · Q4 2026 2027-02-16 ScheduledYear-End Report 2026: 2027-02-16
-
Earnings call · Q3 2026 2026-11-27 ScheduledQ3-report: 2026-11-27
-
Earnings call · Q2 2026 2026-08-28Q2-report: 2026-08-28
-
Earnings call · Q1 2026 2026-04-21Q1-report: 2026-04-21
-
Earnings call · Q4 2025 2026-02-13Year-End Report 2025: 2026-02-13